Friday, March 24, 2023 6:52:25 PM
CEO Michael Frank, like all good 'leaders' tend to do, should recognize investor sentiment after Monday's dire update and subsequent PPS plunge, and exercise some emotional intelligence at this point by addressing shareholders in a somewhat personalized manner - many of my CEO's do this and it proves effective at the best of times. MF and this whole FDA process has had us all sweating for going on 3 years now and the build-up has resulted in this current toilet-PPS.
Most of us Longs are looking at 80+% paper losses at present. MF needs to give us a status update / strategy to believe in. We merit that to say the least.
His silence stance appears both potentially dodgy and guilty in my opinion (mere speculation based on his action and I hope I am proved otherwise soon). Him communicating with us might effectively eliminate this sentiment, reduce the dumping and increase / encourage new investment.
If MF was confident about Bucillamine and Revive's future, he would and absolutely ought to be vocal about it.
I am an optimist by nature however, the crooked OTCM has screwed me left, right and center these past 18 months - 'hope' is no longer a strategy as an investor and based on his radio silence, hope is all MF is leaving us with currently.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM